ReP USP - Resultado da busca

Artigo de periodico
Treatment of rabbits with atherosclerosis induced by cholesterol feeding with daunorubicin associated to a lipid core nanoparticle (LDE) (2023)
Albuquerque, Camila Inagaki ; Tavares, Elaine Rufo ; Guido, Maria Carolina ; Carvalho, Priscila Oliveira de ; Tavoni, Thauany Martins ; Lopes, Natalia de Menezes ; Silva, Bruna Miranda de Oliveira ; Jensen, Leonardo ; Stolf, Noedir Antonio Groppo ; Maranhão, Raul Cavalcante
Source: Journal of Drug Delivery Science and Technology. Unidades: FM, FCF
Subjects: ARTERIOSCLEROSE, NANOPARTÍCULAS, INFLAMAÇÃO, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALBUQUERQUE, Camila Inagaki et al. Treatment of rabbits with atherosclerosis induced by cholesterol feeding with daunorubicin associated to a lipid core nanoparticle (LDE). Journal of Drug Delivery Science and Technology, v. 79, p. 1-10, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jddst.2022.104067. Acesso em: 13 nov. 2024.
APA
Albuquerque, C. I., Tavares, E. R., Guido, M. C., Carvalho, P. O. de, Tavoni, T. M., Lopes, N. de M., et al. (2023). Treatment of rabbits with atherosclerosis induced by cholesterol feeding with daunorubicin associated to a lipid core nanoparticle (LDE). Journal of Drug Delivery Science and Technology, 79, 1-10. doi:10.1016/j.jddst.2022.104067
NLM
Albuquerque CI, Tavares ER, Guido MC, Carvalho PO de, Tavoni TM, Lopes N de M, Silva BM de O, Jensen L, Stolf NAG, Maranhão RC. Treatment of rabbits with atherosclerosis induced by cholesterol feeding with daunorubicin associated to a lipid core nanoparticle (LDE) [Internet]. Journal of Drug Delivery Science and Technology. 2023 ; 79 1-10.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.jddst.2022.104067
Vancouver
Albuquerque CI, Tavares ER, Guido MC, Carvalho PO de, Tavoni TM, Lopes N de M, Silva BM de O, Jensen L, Stolf NAG, Maranhão RC. Treatment of rabbits with atherosclerosis induced by cholesterol feeding with daunorubicin associated to a lipid core nanoparticle (LDE) [Internet]. Journal of Drug Delivery Science and Technology. 2023 ; 79 1-10.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.jddst.2022.104067
Artigo de periodico
TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis (2022)
Duarte, Victor Hugo Rezende ; Cruz, Marina Sampaio; Bertolami, Adriana; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Luchessi, André Ducati ; Silbiger, Vivian Nogueira
Source: Scientifc Reports. Unidade: FCF
Subjects: LEUCÓCITOS, ARTERIOSCLEROSE, BIOMARCADORES, CARDIOLOGIA, BIOLOGIA MOLECULAR, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUARTE, Victor Hugo Rezende et al. TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis. Scientifc Reports, v. 12, p. 1-9 art. 18612, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-22040-3. Acesso em: 13 nov. 2024.
APA
Duarte, V. H. R., Cruz, M. S., Bertolami, A., Hirata, M. H., Hirata, R. D. C., Luchessi, A. D., & Silbiger, V. N. (2022). TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis. Scientifc Reports, 12, 1-9 art. 18612. doi:10.1038/s41598-022-22040-3
NLM
Duarte VHR, Cruz MS, Bertolami A, Hirata MH, Hirata RDC, Luchessi AD, Silbiger VN. TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis [Internet]. Scientifc Reports. 2022 ; 12 1-9 art. 18612.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1038/s41598-022-22040-3
Vancouver
Duarte VHR, Cruz MS, Bertolami A, Hirata MH, Hirata RDC, Luchessi AD, Silbiger VN. TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis [Internet]. Scientifc Reports. 2022 ; 12 1-9 art. 18612.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1038/s41598-022-22040-3
Artigo de periodico
The interplay of sirtuin-1, LDL-cholesterol, and HDL function: a randomized controlled trial comparing the effects of energy restriction and atorvastatin on women with premature coronary artery disease (2022)
Leal, Dalila Pinheiro ; Gonçalinho, Gustavo Henrique Ferreira ; Tavoni, Thauany Martins ; Kuwabara, Karen Lika; Paccanaro, Ana Paula; Freitas, Fatima Rodrigues ; Strunz, Célia Maria Cássaro ; Cesar, Luiz Antonio Machado ; Maranhão, Raul Cavalcante ; Mansur, Antonio de Padua
Source: Antioxidants. Unidades: FM, FCF
Subjects: CORONARIOPATIA, DIETA, ARTERIOSCLEROSE, LIPOPROTEÍNAS HDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Dalila Pinheiro et al. The interplay of sirtuin-1, LDL-cholesterol, and HDL function: a randomized controlled trial comparing the effects of energy restriction and atorvastatin on women with premature coronary artery disease. Antioxidants, v. 11, n. 12, p. 1-13, 2022Tradução . . Disponível em: https://doi.org/10.3390/antiox11122363. Acesso em: 13 nov. 2024.
APA
Leal, D. P., Gonçalinho, G. H. F., Tavoni, T. M., Kuwabara, K. L., Paccanaro, A. P., Freitas, F. R., et al. (2022). The interplay of sirtuin-1, LDL-cholesterol, and HDL function: a randomized controlled trial comparing the effects of energy restriction and atorvastatin on women with premature coronary artery disease. Antioxidants, 11( 12), 1-13. doi:10.3390/antiox11122363
NLM
Leal DP, Gonçalinho GHF, Tavoni TM, Kuwabara KL, Paccanaro AP, Freitas FR, Strunz CMC, Cesar LAM, Maranhão RC, Mansur A de P. The interplay of sirtuin-1, LDL-cholesterol, and HDL function: a randomized controlled trial comparing the effects of energy restriction and atorvastatin on women with premature coronary artery disease [Internet]. Antioxidants. 2022 ; 11( 12): 1-13.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/antiox11122363
Vancouver
Leal DP, Gonçalinho GHF, Tavoni TM, Kuwabara KL, Paccanaro AP, Freitas FR, Strunz CMC, Cesar LAM, Maranhão RC, Mansur A de P. The interplay of sirtuin-1, LDL-cholesterol, and HDL function: a randomized controlled trial comparing the effects of energy restriction and atorvastatin on women with premature coronary artery disease [Internet]. Antioxidants. 2022 ; 11( 12): 1-13.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/antiox11122363
Artigo de periodico
Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model (2022)
Arora, Aastha ; Tripodi, Gustavo Luis; Kareinen, Ilona ; Berg, Martin; Forteza, Maria Josefa ; Gisterå, Anton ; Griepke, Silke; Casagrande, Felipe Beccaria ; Martins, Joilson de Oliveira ; Abdalla, Dulcinéia Saes Parra ; Cole, Jennifer ; Monaco, Claudia ; Ketelhuth, Daniel Francisco Jacon
Source: Intional Journal of Molecular Sciences. Unidade: FCF
Subjects: ARTERIOSCLEROSE, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARORA, Aastha et al. Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model. Intional Journal of Molecular Sciences, v. 23, p. 1-17 art. 5203, 2022Tradução . . Disponível em: https://doi.org/10.3390/ijms23095203. Acesso em: 13 nov. 2024.
APA
Arora, A., Tripodi, G. L., Kareinen, I., Berg, M., Forteza, M. J., Gisterå, A., et al. (2022). Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model. Intional Journal of Molecular Sciences, 23, 1-17 art. 5203. doi:10.3390/ijms23095203
NLM
Arora A, Tripodi GL, Kareinen I, Berg M, Forteza MJ, Gisterå A, Griepke S, Casagrande FB, Martins J de O, Abdalla DSP, Cole J, Monaco C, Ketelhuth DFJ. Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model [Internet]. Intional Journal of Molecular Sciences. 2022 ; 23 1-17 art. 5203.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/ijms23095203
Vancouver
Arora A, Tripodi GL, Kareinen I, Berg M, Forteza MJ, Gisterå A, Griepke S, Casagrande FB, Martins J de O, Abdalla DSP, Cole J, Monaco C, Ketelhuth DFJ. Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model [Internet]. Intional Journal of Molecular Sciences. 2022 ; 23 1-17 art. 5203.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/ijms23095203
Artigo de periodico
Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression (2021)
Leão, Matheus de Castro; Pohlmann, Adriana Raffin ; Alves, Aline de Cristo Soares; Farsky, Sandra Helena Poliselli ; Uchiyama, Mayara Klimuk ; Araki, Koiti ; Sandri, Silvana; Guterres, Sílvia Stanisçuaski ; Castro, Inar Alves de
Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FCF, IQ
Subjects: ARTERIOSCLEROSE, ESTRESSE OXIDATIVO, ÁCIDOS GRAXOS OMEGA 3, NANOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEÃO, Matheus de Castro et al. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression. European Journal of Pharmaceutics and Biopharmaceutics, v. 159, p. 99–107, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2020.12.016. Acesso em: 13 nov. 2024.
APA
Leão, M. de C., Pohlmann, A. R., Alves, A. de C. S., Farsky, S. H. P., Uchiyama, M. K., Araki, K., et al. (2021). Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression. European Journal of Pharmaceutics and Biopharmaceutics, 159, 99–107. doi:10.1016/j.ejpb.2020.12.016
NLM
Leão M de C, Pohlmann AR, Alves A de CS, Farsky SHP, Uchiyama MK, Araki K, Sandri S, Guterres SS, Castro IA de. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 159 99–107.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.ejpb.2020.12.016
Vancouver
Leão M de C, Pohlmann AR, Alves A de CS, Farsky SHP, Uchiyama MK, Araki K, Sandri S, Guterres SS, Castro IA de. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 159 99–107.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.ejpb.2020.12.016
Trabalho de evento-resumo periodico
Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1 (2021)
Leão, Matheus de Castro; Pohlmann, Adriana Raffin ; Farsky, Sandra Helena Poliselli ; Broering, Milena Fronza; Castro, Inar Alves de ; Guterres, Sílvia Stanisçuaski
Source: Atherosclerosis. Conference titles: Congress European Atherosclerosis Society/EAS. Unidade: FCF
Subjects: ARTERIOSCLEROSE, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEÃO, Matheus de Castro et al. Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://pdf.sciencedirectassets.com/271064/1-s2.0-S0021915021X00147/1-s2.0-S0021915021004846/main.pdf? Acesso em: 13 nov. 2024. , 2021
APA
Leão, M. de C., Pohlmann, A. R., Farsky, S. H. P., Broering, M. F., Castro, I. A. de, & Guterres, S. S. (2021). Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de https://pdf.sciencedirectassets.com/271064/1-s2.0-S0021915021X00147/1-s2.0-S0021915021004846/main.pdf?
NLM
Leão M de C, Pohlmann AR, Farsky SHP, Broering MF, Castro IA de, Guterres SS. Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1 [Internet]. Atherosclerosis. 2021 ; 331 e73 res. P053.[citado 2024 nov. 13 ] Available from: https://pdf.sciencedirectassets.com/271064/1-s2.0-S0021915021X00147/1-s2.0-S0021915021004846/main.pdf?
Vancouver
Leão M de C, Pohlmann AR, Farsky SHP, Broering MF, Castro IA de, Guterres SS. Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1 [Internet]. Atherosclerosis. 2021 ; 331 e73 res. P053.[citado 2024 nov. 13 ] Available from: https://pdf.sciencedirectassets.com/271064/1-s2.0-S0021915021X00147/1-s2.0-S0021915021004846/main.pdf?
Artigo de periodico
Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione (2021)
Garcia, Giani Martins; Roy, Jérôme; Pitta, Ivan R; Abdalla, Dulcinéia Saes Parra ; Guimarães, Andrea Grabe ; Mosqueira, Vanessa Carla Furtado ; Richard, Sylvain
Source: Pharmaceutics. Unidade: FCF
Subjects: NANOPARTÍCULAS, ARTERIOSCLEROSE, SÍNDROME X METABÓLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Giani Martins et al. Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione. Pharmaceutics, v. 13, p. 1-13 art. 1521, 2021Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics13091521. Acesso em: 13 nov. 2024.
APA
Garcia, G. M., Roy, J., Pitta, I. R., Abdalla, D. S. P., Guimarães, A. G., Mosqueira, V. C. F., & Richard, S. (2021). Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione. Pharmaceutics, 13, 1-13 art. 1521. doi:10.3390/pharmaceutics13091521
NLM
Garcia GM, Roy J, Pitta IR, Abdalla DSP, Guimarães AG, Mosqueira VCF, Richard S. Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione [Internet]. Pharmaceutics. 2021 ; 13 1-13 art. 1521.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/pharmaceutics13091521
Vancouver
Garcia GM, Roy J, Pitta IR, Abdalla DSP, Guimarães AG, Mosqueira VCF, Richard S. Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione [Internet]. Pharmaceutics. 2021 ; 13 1-13 art. 1521.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/pharmaceutics13091521
Artigo de periodico
L-glutamine supplementation enhances glutathione peroxidase and paraoxonase-1 activities in HDL of exercising older individuals (2021)
Pires, Renier S; Braga, Pedro Gabriel Senger ; Santos, Juliana M. B; Amaral, Jônatas Bussador do ; Amirato, Gislene R; Trettel, Caio dos Santos ; Santos, Carlos A. F. dos; Vaisberg, Mauro ; Nali, Luiz Henrique da Silva ; Vieira, Rodolfo de Paula ; Maranhão, Raul Cavalcante ; Curi, Tania Cristina Phiton ; Barros, Marcelo Paes de ; Bachi, André Luis Lacerda
Source: Experimental Gerontology. Unidades: FCF, FM
Subjects: GLUTAMINA, ANTIOXIDANTES, RADICAIS LIVRES, ARTERIOSCLEROSE, INFLAMAÇÃO, LIPOPROTEÍNAS LDL, COLESTEROL, ESTRESSE OXIDATIVO, DOENÇAS CARDIOVASCULARES, AMINOÁCIDOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIRES, Renier S et al. L-glutamine supplementation enhances glutathione peroxidase and paraoxonase-1 activities in HDL of exercising older individuals. Experimental Gerontology, v. 156, p. 1-10 art. 111584, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.exger.2021.111584. Acesso em: 13 nov. 2024.
APA
Pires, R. S., Braga, P. G. S., Santos, J. M. B., Amaral, J. B. do, Amirato, G. R., Trettel, C. dos S., et al. (2021). L-glutamine supplementation enhances glutathione peroxidase and paraoxonase-1 activities in HDL of exercising older individuals. Experimental Gerontology, 156, 1-10 art. 111584. doi:10.1016/j.exger.2021.111584
NLM
Pires RS, Braga PGS, Santos JMB, Amaral JB do, Amirato GR, Trettel C dos S, Santos CAF dos, Vaisberg M, Nali LH da S, Vieira R de P, Maranhão RC, Curi TCP, Barros MP de, Bachi ALL. L-glutamine supplementation enhances glutathione peroxidase and paraoxonase-1 activities in HDL of exercising older individuals [Internet]. Experimental Gerontology. 2021 ; 156 1-10 art. 111584.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.exger.2021.111584
Vancouver
Pires RS, Braga PGS, Santos JMB, Amaral JB do, Amirato GR, Trettel C dos S, Santos CAF dos, Vaisberg M, Nali LH da S, Vieira R de P, Maranhão RC, Curi TCP, Barros MP de, Bachi ALL. L-glutamine supplementation enhances glutathione peroxidase and paraoxonase-1 activities in HDL of exercising older individuals [Internet]. Experimental Gerontology. 2021 ; 156 1-10 art. 111584.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.exger.2021.111584
Artigo de periodico
scFv-Anti-LDL(-)-metal-complex multi-wall functionalized-nanocapsules as a promising tool for the prevention of atherosclerosis progression (2021)
Cavalcante, Marcela Frota; Adorne, Márcia Duarte; Turato, Walter Miguel; Kemmerer, Marina; Uchiyama, Mayara Klimuk ; Asbahr, Ana Carolina Cavazzin; Alves, Aline de Cristo Soares; Farsky, Sandra Helena Poliselli ; Drewes, Carine; Spatti, Marina Cecília; Kazuma, Soraya Megumi; Boss, Marcel; Guterres, Silvia Stanisçuaski ; Araki, Koiti ; Brüne, Bernhard; Namgaladze, Dmitry; Pohlmann, Adriana Raffin ; Abdalla, Dulcinéia Saes Parra
Source: Frontiers in Medicine. Unidades: FCF, IQ
Subjects: ARTERIOSCLEROSE, LIPOPROTEÍNAS LDL, NANOTECNOLOGIA, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVALCANTE, Marcela Frota et al. scFv-Anti-LDL(-)-metal-complex multi-wall functionalized-nanocapsules as a promising tool for the prevention of atherosclerosis progression. Frontiers in Medicine, v. 8, p. 1-14 art. 652137, 2021Tradução . . Disponível em: https://doi.org/10.3389/fmed.2021.652137. Acesso em: 13 nov. 2024.
APA
Cavalcante, M. F., Adorne, M. D., Turato, W. M., Kemmerer, M., Uchiyama, M. K., Asbahr, A. C. C., et al. (2021). scFv-Anti-LDL(-)-metal-complex multi-wall functionalized-nanocapsules as a promising tool for the prevention of atherosclerosis progression. Frontiers in Medicine, 8, 1-14 art. 652137. doi:10.3389/fmed.2021.652137
NLM
Cavalcante MF, Adorne MD, Turato WM, Kemmerer M, Uchiyama MK, Asbahr ACC, Alves A de CS, Farsky SHP, Drewes C, Spatti MC, Kazuma SM, Boss M, Guterres SS, Araki K, Brüne B, Namgaladze D, Pohlmann AR, Abdalla DSP. scFv-Anti-LDL(-)-metal-complex multi-wall functionalized-nanocapsules as a promising tool for the prevention of atherosclerosis progression [Internet]. Frontiers in Medicine. 2021 ; 8 1-14 art. 652137.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/fmed.2021.652137
Vancouver
Cavalcante MF, Adorne MD, Turato WM, Kemmerer M, Uchiyama MK, Asbahr ACC, Alves A de CS, Farsky SHP, Drewes C, Spatti MC, Kazuma SM, Boss M, Guterres SS, Araki K, Brüne B, Namgaladze D, Pohlmann AR, Abdalla DSP. scFv-Anti-LDL(-)-metal-complex multi-wall functionalized-nanocapsules as a promising tool for the prevention of atherosclerosis progression [Internet]. Frontiers in Medicine. 2021 ; 8 1-14 art. 652137.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/fmed.2021.652137
Artigo de periodico
Prodigiosin modulates the immune response and could promote a stable atherosclerotic lession in C57bl/6 Ldlr-/- Mice (2020)
Cuevas, Alejandro ; Saavedra, Nicolás ; Salazar, Luis A; Cavalcante, Marcela Frota; Silva, Jacqueline Cavalcante ; Abdalla, Dulcinéia Saes Parra
Source: International Journal of Molecular Sciences. Unidade: FCF
Subjects: ARTERIOSCLEROSE, METABÓLITOS SECUNDÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUEVAS, Alejandro et al. Prodigiosin modulates the immune response and could promote a stable atherosclerotic lession in C57bl/6 Ldlr-/- Mice. International Journal of Molecular Sciences, v. 21, p. 1-18 art. 6417, 2020Tradução . . Disponível em: https://doi.org/10.3390/ijms21176417. Acesso em: 13 nov. 2024.
APA
Cuevas, A., Saavedra, N., Salazar, L. A., Cavalcante, M. F., Silva, J. C., & Abdalla, D. S. P. (2020). Prodigiosin modulates the immune response and could promote a stable atherosclerotic lession in C57bl/6 Ldlr-/- Mice. International Journal of Molecular Sciences, 21, 1-18 art. 6417. doi:10.3390/ijms21176417
NLM
Cuevas A, Saavedra N, Salazar LA, Cavalcante MF, Silva JC, Abdalla DSP. Prodigiosin modulates the immune response and could promote a stable atherosclerotic lession in C57bl/6 Ldlr-/- Mice [Internet]. International Journal of Molecular Sciences. 2020 ; 21 1-18 art. 6417.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/ijms21176417
Vancouver
Cuevas A, Saavedra N, Salazar LA, Cavalcante MF, Silva JC, Abdalla DSP. Prodigiosin modulates the immune response and could promote a stable atherosclerotic lession in C57bl/6 Ldlr-/- Mice [Internet]. International Journal of Molecular Sciences. 2020 ; 21 1-18 art. 6417.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/ijms21176417
Artigo de periodico
Inflammasome activation in human macrophages induced by a LDL (−) mimetic peptide (2020)
Tripodi, Gustavo Luis; Prieto, Marcela Bach; Abdalla, Dulcinéia Saes Parra
Source: Inflammation. Unidade: FCF
Subjects: MACRÓFAGOS, PEPTÍDEOS, INTERLEUCINAS, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TRIPODI, Gustavo Luis e PRIETO, Marcela Bach e ABDALLA, Dulcinéia Saes Parra. Inflammasome activation in human macrophages induced by a LDL (−) mimetic peptide. Inflammation, v. 43, n. 2 p. 722-730, 2020Tradução . . Disponível em: https://doi.org/10.1007/s10753-019-01159-y. Acesso em: 13 nov. 2024.
APA
Tripodi, G. L., Prieto, M. B., & Abdalla, D. S. P. (2020). Inflammasome activation in human macrophages induced by a LDL (−) mimetic peptide. Inflammation, 43( 2 p. 722-730). doi:10.1007/s10753-019-01159-y
NLM
Tripodi GL, Prieto MB, Abdalla DSP. Inflammasome activation in human macrophages induced by a LDL (−) mimetic peptide [Internet]. Inflammation. 2020 ; 43( 2 p. 722-730):[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s10753-019-01159-y
Vancouver
Tripodi GL, Prieto MB, Abdalla DSP. Inflammasome activation in human macrophages induced by a LDL (−) mimetic peptide [Internet]. Inflammation. 2020 ; 43( 2 p. 722-730):[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s10753-019-01159-y
Trabalho de evento-resumo
Validation of TREML4 mRNA expression and polymorphisms in blood leukocytes as potential biomarker of atherosclerosis (2019)
Duarte, V. H. R; Manfredi, A. B; Araújo, J. N; Borges, J. B; Bastos, G. M; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Luchessi, André Ducati; Silbiger, Vivian Nogueira
Source: Abstracts. Conference titles: American Association for Clinical Chemistry/AACC. Unidade: FCF
Subjects: POLIMORFISMO, BIOMARCADORES, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUARTE, V. H. R et al. Validation of TREML4 mRNA expression and polymorphisms in blood leukocytes as potential biomarker of atherosclerosis. 2019, Anais.. Washington: AACC, 2019. . Acesso em: 13 nov. 2024.
APA
Duarte, V. H. R., Manfredi, A. B., Araújo, J. N., Borges, J. B., Bastos, G. M., Hirata, M. H., et al. (2019). Validation of TREML4 mRNA expression and polymorphisms in blood leukocytes as potential biomarker of atherosclerosis. In Abstracts. Washington: AACC.
NLM
Duarte VHR, Manfredi AB, Araújo JN, Borges JB, Bastos GM, Hirata MH, Hirata RDC, Luchessi AD, Silbiger VN. Validation of TREML4 mRNA expression and polymorphisms in blood leukocytes as potential biomarker of atherosclerosis. Abstracts. 2019 ;[citado 2024 nov. 13 ]
Vancouver
Duarte VHR, Manfredi AB, Araújo JN, Borges JB, Bastos GM, Hirata MH, Hirata RDC, Luchessi AD, Silbiger VN. Validation of TREML4 mRNA expression and polymorphisms in blood leukocytes as potential biomarker of atherosclerosis. Abstracts. 2019 ;[citado 2024 nov. 13 ]
Artigo de periodico
Increased levels of plasma IL-1b and BDNF can predict resistant depression patients (2019)
Uint, Luciana ; Bastos, Gisele Medeiros ; Thurow, Helena Strelow ; Borges, Jéssica Bassani ; Hirata, Thiago Dominguez Crespo ; França, Joao Italo Dias ; Hirata, Mario Hiroyuki ; Sousa, Amanda Guerra de Moraes Rego
Source: Revista da Associação Medica Brasileira. Unidade: FCF
Subjects: TRANSTORNO BIPOLAR, DEPRESSÃO, INFLAMAÇÃO, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
UINT, Luciana et al. Increased levels of plasma IL-1b and BDNF can predict resistant depression patients. Revista da Associação Medica Brasileira, v. 65, n. 3, p. 361-369, 2019Tradução . . Disponível em: https://doi.org/10.1590/1806-9282.65.3.361. Acesso em: 13 nov. 2024.
APA
Uint, L., Bastos, G. M., Thurow, H. S., Borges, J. B., Hirata, T. D. C., França, J. I. D., et al. (2019). Increased levels of plasma IL-1b and BDNF can predict resistant depression patients. Revista da Associação Medica Brasileira, 65( 3), 361-369. doi:10.1590/1806-9282.65.3.361
NLM
Uint L, Bastos GM, Thurow HS, Borges JB, Hirata TDC, França JID, Hirata MH, Sousa AG de MR. Increased levels of plasma IL-1b and BDNF can predict resistant depression patients [Internet]. Revista da Associação Medica Brasileira. 2019 ; 65( 3): 361-369.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1590/1806-9282.65.3.361
Vancouver
Uint L, Bastos GM, Thurow HS, Borges JB, Hirata TDC, França JID, Hirata MH, Sousa AG de MR. Increased levels of plasma IL-1b and BDNF can predict resistant depression patients [Internet]. Revista da Associação Medica Brasileira. 2019 ; 65( 3): 361-369.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1590/1806-9282.65.3.361
Artigo de periodico
Proinflammatory action of a new electronegative low-density lipoprotein epitope (2019)
Faulin, Tanize do Espírito Santo; Kazuma, Soraya Megumi; Tripodi, Gustavo Luis; Cavalcante, Marcela Frota; Wakasuqui, Felipe; Oliveira, Cristiano Luis Pinto de; Degenhardt, Maximilia Frazão de Souza; Michaloski, Jussara; Giordano, Ricardo José ; Ketelhuth, Daniel Francisco Jacon; Abdalla, Dulcinéia Saes Parra
Source: Biomolecules. Unidades: IF, IQ, FCF
Subjects: ARTERIOSCLEROSE, MACRÓFAGOS, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAULIN, Tanize do Espírito Santo et al. Proinflammatory action of a new electronegative low-density lipoprotein epitope. Biomolecules, v. 9, n. 8, p. 1-17 art. 386, 2019Tradução . . Disponível em: https://doi.org/10.3390/biom9080386. Acesso em: 13 nov. 2024.
APA
Faulin, T. do E. S., Kazuma, S. M., Tripodi, G. L., Cavalcante, M. F., Wakasuqui, F., Oliveira, C. L. P. de, et al. (2019). Proinflammatory action of a new electronegative low-density lipoprotein epitope. Biomolecules, 9( 8), 1-17 art. 386. doi:10.3390/biom9080386
NLM
Faulin T do ES, Kazuma SM, Tripodi GL, Cavalcante MF, Wakasuqui F, Oliveira CLP de, Degenhardt MF de S, Michaloski J, Giordano RJ, Ketelhuth DFJ, Abdalla DSP. Proinflammatory action of a new electronegative low-density lipoprotein epitope [Internet]. Biomolecules. 2019 ; 9( 8): 1-17 art. 386.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/biom9080386
Vancouver
Faulin T do ES, Kazuma SM, Tripodi GL, Cavalcante MF, Wakasuqui F, Oliveira CLP de, Degenhardt MF de S, Michaloski J, Giordano RJ, Ketelhuth DFJ, Abdalla DSP. Proinflammatory action of a new electronegative low-density lipoprotein epitope [Internet]. Biomolecules. 2019 ; 9( 8): 1-17 art. 386.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/biom9080386
Trabalho de evento-resumo periodico
Methotrexate reduces cardiac remodeling and improves left ventricle function in rats with Takotsubo cardiomyopathy (2019)
Guido, M. C; Lopes, N. M; Tavares, E. R; Bispo, D. L; Tavares De Melo, M. D; Salemi, Vera M. C; Maranhão, Raul Cavalcante
Conference titles: European Society of cardiology Congress/ESC. Unidade: FCF
Subjects: ARTERIOSCLEROSE, ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIDO, M. C et al. Methotrexate reduces cardiac remodeling and improves left ventricle function in rats with Takotsubo cardiomyopathy. . Oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 13 nov. 2024. , 2019
APA
Guido, M. C., Lopes, N. M., Tavares, E. R., Bispo, D. L., Tavares De Melo, M. D., Salemi, V. M. C., & Maranhão, R. C. (2019). Methotrexate reduces cardiac remodeling and improves left ventricle function in rats with Takotsubo cardiomyopathy. Oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Guido MC, Lopes NM, Tavares ER, Bispo DL, Tavares De Melo MD, Salemi VMC, Maranhão RC. Methotrexate reduces cardiac remodeling and improves left ventricle function in rats with Takotsubo cardiomyopathy. 2019 ;40 3899 res. P6295.[citado 2024 nov. 13 ]
Vancouver
Guido MC, Lopes NM, Tavares ER, Bispo DL, Tavares De Melo MD, Salemi VMC, Maranhão RC. Methotrexate reduces cardiac remodeling and improves left ventricle function in rats with Takotsubo cardiomyopathy. 2019 ;40 3899 res. P6295.[citado 2024 nov. 13 ]
Artigo de periodico
Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model (2019)
Meneghini, Bianca C; Tavares, Elaine R; Guido, Maria C; Tavoni, Thauany M; Stefani, Hélio Alexandre ; Kalil-filho, Roberto; Maranhão, Raul Cavalcante
Source: Vascular pharmacology. Unidades: FM, FCF
Subjects: NANOPARTÍCULAS, LIPÍDEOS, ANTINEOPLÁSICOS, ARTERIOSCLEROSE, INFLAMAÇÃO, COELHOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENEGHINI, Bianca C et al. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Vascular pharmacology, v. 115, p. 46-54, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.vph.2019.02.003. Acesso em: 13 nov. 2024.
APA
Meneghini, B. C., Tavares, E. R., Guido, M. C., Tavoni, T. M., Stefani, H. A., Kalil-filho, R., & Maranhão, R. C. (2019). Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Vascular pharmacology, 115, 46-54. doi:10.1016/j.vph.2019.02.003
NLM
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Stefani HA, Kalil-filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model [Internet]. Vascular pharmacology. 2019 ; 115 46-54.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.vph.2019.02.003
Vancouver
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Stefani HA, Kalil-filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model [Internet]. Vascular pharmacology. 2019 ; 115 46-54.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.vph.2019.02.003
Trabalho de evento-resumo periodico
Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model (2018)
Meneghini, Bianca Correa; Tavares, Elaine Rufo; Guido, Maria Carolina; Tavoni, Thauany Martins; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: International Symposium on Atherosclerosis/ISA. Unidades: FM, FCF
Subjects: NANOPARTÍCULAS, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENEGHINI, Bianca Correa et al. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf. Acesso em: 13 nov. 2024. , 2018
APA
Meneghini, B. C., Tavares, E. R., Guido, M. C., Tavoni, T. M., Kalil Filho, R., & Maranhão, R. C. (2018). Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
NLM
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 32 112-113 res. P3.088.[citado 2024 nov. 13 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Vancouver
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 32 112-113 res. P3.088.[citado 2024 nov. 13 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Trabalho de evento-resumo periodico
Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure (2018)
Drager, Luciano Ferreira; Tavoni, Thauany Martins; Silva, Vanessa Martins da; Santos, Raul Dias dos; Pedrosa, Rodrigo Pinto; Bortolotto, Luiz Aparecido; Vinagre, Carmen Guilherme Christiano de Matos; Polotsky, Vsevolod Y; Lorenzi Filho, Geraldo; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: International Symposium on Atherosclerosis/ISA. Unidades: FM, FCF
Subjects: APNEIA DO SONO, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira et al. Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf. Acesso em: 13 nov. 2024. , 2018
APA
Drager, L. F., Tavoni, T. M., Silva, V. M. da, Santos, R. D. dos, Pedrosa, R. P., Bortolotto, L. A., et al. (2018). Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
NLM
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 32 63-64 res. P1.099.[citado 2024 nov. 13 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Vancouver
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 32 63-64 res. P1.099.[citado 2024 nov. 13 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Parte de monografia/livro
Artificial lipoproteins in endothelial dysfunction and atherosclerosis (2018)
Maranhão, Raul Cavalcante
Source: Endothelium and Cardiovascular Diseases: Vascular Biology and Clinical Syndromes. Unidade: FCF
Subjects: ENDOTÉLIO, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante. Artificial lipoproteins in endothelial dysfunction and atherosclerosis. Endothelium and Cardiovascular Diseases: Vascular Biology and Clinical Syndromes. Tradução . India: Mica Haley, 2018. . . Acesso em: 13 nov. 2024.
APA
Maranhão, R. C. (2018). Artificial lipoproteins in endothelial dysfunction and atherosclerosis. In Endothelium and Cardiovascular Diseases: Vascular Biology and Clinical Syndromes. India: Mica Haley.
NLM
Maranhão RC. Artificial lipoproteins in endothelial dysfunction and atherosclerosis. In: Endothelium and Cardiovascular Diseases: Vascular Biology and Clinical Syndromes. India: Mica Haley; 2018. [citado 2024 nov. 13 ]
Vancouver
Maranhão RC. Artificial lipoproteins in endothelial dysfunction and atherosclerosis. In: Endothelium and Cardiovascular Diseases: Vascular Biology and Clinical Syndromes. India: Mica Haley; 2018. [citado 2024 nov. 13 ]
Artigo de periodico
Removal of chylomicron remnants from the bloodstream is delayed in aged subjects (2018)
Vinagre, Carmen G; Freitas, Fatima R; Mesquita, Carlos Henrique de; Vinagre, Juliana C; Mariani, Ana Carolina; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: Aging and Disease. Unidades: FM, FCF
Subjects: ENVELHECIMENTO, ARTERIOSCLEROSE, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VINAGRE, Carmen G et al. Removal of chylomicron remnants from the bloodstream is delayed in aged subjects. Aging and Disease, v. 9, n. 4, p. 748-754, 2018Tradução . . Disponível em: https://doi.org/10.14336/AD.2017.1003. Acesso em: 13 nov. 2024.
APA
Vinagre, C. G., Freitas, F. R., Mesquita, C. H. de, Vinagre, J. C., Mariani, A. C., Kalil Filho, R., & Maranhão, R. C. (2018). Removal of chylomicron remnants from the bloodstream is delayed in aged subjects. Aging and Disease, 9( 4), 748-754. doi:10.14336/AD.2017.1003
NLM
Vinagre CG, Freitas FR, Mesquita CH de, Vinagre JC, Mariani AC, Kalil Filho R, Maranhão RC. Removal of chylomicron remnants from the bloodstream is delayed in aged subjects [Internet]. Aging and Disease. 2018 ; 9( 4): 748-754.[citado 2024 nov. 13 ] Available from: https://doi.org/10.14336/AD.2017.1003
Vancouver
Vinagre CG, Freitas FR, Mesquita CH de, Vinagre JC, Mariani AC, Kalil Filho R, Maranhão RC. Removal of chylomicron remnants from the bloodstream is delayed in aged subjects [Internet]. Aging and Disease. 2018 ; 9( 4): 748-754.[citado 2024 nov. 13 ] Available from: https://doi.org/10.14336/AD.2017.1003

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Grupo de pesquisa

Funding Agencies

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration